Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Capita signs learning services contract renewal worth up to £124m with major UK financial services client
Capita plc (‘Capita’) today announces it has been awarded a contract renewal to provide a range of learning services for a major UK financial services institution.
Building on a long-term partnership, the contract renewal – which started on 1 July 2021 – is worth up to £123.6m over five-and-a-half years.
Capita is already a trusted partner to the client, providing a broad range of learning services, as well as market insight and thought leadership. These services include learning consultancy, virtual and face-to-face learning programmes, and digital and simulated learning.
Capita, through its Capita Learning business, will provide end-to-end learning services to the client in a more innovative, digital and efficient way under the renewed contract, partly as a result of Capita Learning’s recent transformation.
Capita is also responsible for procurement and management of any third-party learning suppliers to the client, including administrating training and the sourcing of learning professionals to deliver on client projects.
The contract, which will directly service the learning needs of the client’s employees, will be delivered by a team of 40 skilled Capita colleagues based in Reading and Poland.
This is a significant renewal with a major client for Capita and forms an integral part of the company’s ongoing transformation, supporting the delivery of improving financial returns. The contract was won following a competitive bid process.
Jon Lewis, Chief Executive Officer of Capita, said: “This contract renewal demonstrates the strength and success of the long-term strategic partnership we have with our client.
“As a result of working closely and collaboratively as a learning partner for a number of years, we have been able to understand and adapt to their changing needs effectively, ensuring they always have access to the skills they and their people need”.
Notes to editors:
The majority of the contract is based on historical and expected volumes, and therefore treated as transactional revenue. The IFRS 15 transaction price (order book) for the five-and-a-half-year contract renewal is £4.2m.
For more information, please contact:
Investor enquiries
Stuart Morgan
Director of Investor Relations
Tel: 07989 665484
Email: IRteam@capita.co.uk
Media enquiries
Capita external communications
Tel: 0207 654 2399
Email: media@capita.co.uk
About Capita
Capita is a consulting, transformation and digital services business. Every day our 55,000 colleagues help millions of people, by delivering innovative solutions to transform and simplify the connections between government and citizens, businesses and customers. We partner with our clients and provide the insight and cutting-edge technologies that give time back, allowing them to focus on what they do best, and making people’s lives easier
Capita plc Alerts
Thu 01/07/2021 11:06
1 July 2021
Capita plc
(the “Company”)
Voting Rights and Capital
Notification of alteration to total voting rights in accordance with the FCA's Disclosure Guidance and Transparency Rules provision 5.6.1R.
The Company advises that its capital consists of 1,684,273,523 ordinary shares of 2 1/15p each, as at 30 June 2021. The voting rights of these shares are identical with each share carrying the right to one vote. The Company currently holds no ordinary shares in Treasury. Therefore, the total number of voting rights in Capita plc is 1,684,273,523.
The above figure, 1,684,273,523 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, Capita plc under the FCA's Disclosure Guidance and Transparency Rules.
In addition, the above figure includes 20,436,413 shares currently held by the Capita Employee Benefit Trust and therefore excluded from the Company’s EPS calculation.
Name and signature of duly authorised officer of issuer responsible for making notification:
Francesca Todd, Group Company Secretary, 020 7202 0641
==
Capita plc Email Alerts
Brought to you by Brighter
To change your preferences, click here to log in
tatement includes inside information
Capita plc
21 June 2021
MARKET UPDATE
Capita plc (Capita) remains on track to deliver growth and strengthen its balance sheet
Trading
We have seen an improving trend in our trading performance in the first half of the year, in line with our expectations.
Capita remains on track to deliver revenue growth in 2021, for the first time in six years, despite the ongoing impact of COVID lockdowns, in particular in its Specialist Services division.
We have won a number of significant contracts this year, including the Royal Navy Training contract through our Government Services and People Solutions divisions (Total Contract Value £925m), the extension of a European telecoms client (TCV £528m) and an extension for Tesco Mobile (TCV £58m), both in Customer Management.
As a result, we currently expect Half Year adjusted revenue to be flat on prior year adjusted revenue.
Our operational performance has been good, with a positive start to our Royal Navy Training contract and successful ‘go-lives’ for Irish Water in April and on GP Payments and Pensions in May.
We continue to make good progress with our cost saving programme which, together with an improving mix from new contract wins and stronger operational performance, will see the initial benefits of operating leverage at the half year, as expected.
Cash collection has improved in line with underlying trading performance and benefited from better than anticipated customer payments. Liquidity remains strong at £689m on 17 June, ahead of the scheduled repayment of c.£160m of private placement notes in July.
Non-core disposals
We continue to deliver on our plans, set out in March, to strengthen the balance sheet over the course of 2021.
We are making good progress with our planned disposals, and we remain on track to realise combined proceeds of at least £200m in 2021 (in addition to the £299m initial payment received from the sale of ESS in February).
The first of these, the sale of Axelos for an enterprise value of £380m, which will generate total cash proceeds to Capita of £184m, was announced this morning.
Preparation for the sale of other non-core businesses, which will be held in our new division Capita Portfolio, is also progressing well. We will provide further updates as appropriate.
Future Capita
We are well advanced in our plans to implement the next phase of our transformation.
In August we will move to the new structure of two core divisions, Capita Public Service and Capita Experience, and the third division holding our non-core assets, Capita Portfolio.
Capita remains on track to deliver £50m of annualised cost savings from 2022 onwards, associated with this structure, as announced in March.
Our half year 2021 numbers will be reported under the current operating structure, with Full Year 2021 being reported in the new structure.
Jon Lewis, Chief Executive Officer said:
“I’m pleased with
ication
Capita plc announces that an application has been made to the Financial Conduct Authority and the London Stock Exchange for the block listing of a total of 30,000,000 ordinary shares of 2 1/15 pence each (the 'Ordinary Shares'). The block listing application relates to Ordinary Shares to be issued from time to time pursuant to the exercise of share options under the Capita Employee Share Plans.
When issued, these Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing issued Ordinary Shares of the Company. It is expected that admission will become effective for the Ordinary Shares on 16 April 2021.
For more information, please contact:
Francesca Todd, Group Company Secretary, 0207 799 1525
About Capita
Capita is a consulting, transformation and digital services business. Every day our 61,000 colleagues help millions of people, by delivering innovative solutions to transform and simplify the connections between businesses and customers, governments and citizens. We partner with clients and provide the insight and cutting-edge technologies that give time back, allowing them to focus on what they do best and making people’s lives easier and simpler. We operate in the UK, Europe, India and South Africa – and across six divisions: Customer Management; Government Services; People Solutions; Software; Specialist Services; and Technology Solutions. Capita is quoted on the London Stock Exchange (CPI.L). Further information can be found at: http://www.capita.com
Pharm2Farm’s antiviral Type IIR face mask, Pro-Larva, has been approved by UK’s Medicines and Healthcare products Regulatory Agency as a Class 1 Medical device. #RMS
This is a bad ,never any news, Had high hopes of this not to be
yes im a crook
Its about time we had a Mission Statement,every ones clutching @straws can't believe anymore
cant vote 212
(“Capita”)Completion of the sale of Education Software Solutions (“ESS”) businessCapita is pleased to announce that it has completed the sale of its ESS business to Tiger UK Bidco Limited, a newly formed company established by funds advised by Montagu Private Equity (“Montagu”).As previously announced on 14 December 2020 and 14 January 2021, the disposal of the ESS business, a standalone business within the Capita group, supports Capita’s ongoing strategy to “simplify, strengthen and succeed”.The cash proceeds paid by Montagu in respect of the disposal were £298.5m. As previously announced, an additional sum of £45m will be payable by Montagu to Capita following receipt of certain regulatory approvals in respect of Montagu’s agreed investment in ParentPay (Holdings) Ltd.In accordance with the shareholder circular dated 16 December 2020, the net proceeds from the disposal will be used to strengthen Capita’s balance sheet and build a more focused, sustainable business for the long term. Approximately £50m of those proceeds will be used to replace the remaining value of an asset-backed financing agreement, relating to intellectual property developed by ESS, which was entered into in 2012 with the Capita pension scheme through the Capita Scotland (Pension) Limited Partnership.For more information please contact:
And were way behind
Very Quiet is dr cave 2 months now
i should say tb loving this. could of set this up himself or 1 of his companion friends,win or lose i suppose?
LETTER FROM THE CHAIRMAN
Directors: Registered Office:
Antony Legge (Non-Executive Chairman)
John Richardson (Executive Director)
Alex Vergopoulos (Executive Director)
Trevor Brown (Non-Executive Director)
Richard Clarke (Non-Executive Director)
27-28 Eastcastle Street
London
United Kingdom
W1W 8DH
To the Shareholders and, for information only, to the holders of warrants and options
26 January 2021
Dear Shareholder
Proposed issue of 420,000,000 warrants and Notice of General Meeting
1. Introduction
Authority to issue the Warrants
On 18 December 2020, the Company announced that it had raised gross proceeds of £5,000,000
through an oversubscribed placing of 400,000,000 new Ordinary Shares (the “Placing Shares”) at a
price of 1.25 pence per Placing Share (the “Placing”). The Placing Shares commenced trading on
AIM on 23 December 2020.
For each Placing Share subscribed for, each investor participating in the Placing is entitled to
receive one non-transferrable warrant to subscribe for an Ordinary Share with an exercise period of
3 months from its issuance (subject to any extension) and exercisable at a price of 2 pence per
Ordinary Share (the “Placing Warrants”).
In addition, the Company is issuing a further 10,000,000 warrants to each of Peterhouse and SP
Angel (the “Joint Brokers”) pursuant to two separate placing agreements dated 18 December 2020
with the Joint Brokers (the “Broker Warrants”).
If, once issued, the Placing Warrants and Broker Warrants (together the “Warrants”) are exercised
in full, it would result in the issue of a further 420,000,000 new Ordinary Shares.
The Board acknowledges that following the Placing and the conditional grant of the Warrants, few
Shareholders have expressed their concerns about the potential dilution that may arise to their
shareholding in the Company when the Warrants are exercised. As a result of those concerns,
various changes to the Board took place, including the appointment of three new directors. The
purpose of this Document is to comply with the terms of the Placing, pursuant to which the
Company is obliged to call a general meeting of its Shareholders and place the necessary
resolution to the Shareholders to approve the grant of the Warrants.
The grant of the Warrants is conditional upon Resolutions 1 and 2 detailed below being passed by
the relevant majority of Shareholders.
General Authorities
It is usual for quoted companies to possess the authorities to issue shares up to a certain limit and
to disapply pre-emption rights without the need for recourse to shareholders, in order to allow the
Company the flexibility to react to events. For AIM listed companies, this authority is usually in the
range of 10% to 30% of the issued share capital.
In addition to the Resolutions 1 and 2, relating to the grant of the Warrants, the Directors are
seeking authorities to allot and issue shares or grant rights to subscribe for shares in the Company
up to a maximum agg
Please note that arrangements for the General Meeting to be held at the offices of
Pharm2Farm Ltd, BioCity Nottingham, Pennyfoot Street, Nottingham NG1 1GF at 1.00 p.m. on
12 February 2021 are different from those of previous years given that we expect significant
restrictions on personal movement to still be in place due to Covid-19. The Board requests that no
Shareholders attend the meeting in person. Any Shareholders that do attend in person will be
refused entry. Only those who are required to form the quorum will attend in person and those
Shareholders will constitute the minimum quorum for the meeting to take place. Shareholders are
encouraged to vote by appointing the Chairman of the Company as proxy. Shareholders can vote by
returning the Form of Proxy instructions that you received with this Document.
HOW TO ASK A QUESTION
Shareholders will be able to listen to and view the General Meeting via the electronic
platform, details of which will be made available on the Company’s website
(https: https://www.remotemonitoredsystems.com/investor-relations/documents/) in advance
of the General Meeting. To ensure that only registered Shareholders are able to put
questions to the Board, Shareholders will not be able to ask questions via the electronic
platform but instead can submit questions to the Board in relation to the Resolutions and
business of the General Meeting only in advance of the General Meeting by
emailing: info@remotemonitoredsystems.com by no later than 1.00 p.m. on 10 February
2021 or 48 hours before any adjourned meeting. Please include your full name. Only
questions in relation to the Resolutions or business of the General Meeting will be
astrazeneca-vaccine-factory-from-flooding-lbc-idUSL9N2DM01N
Nothing will change. All mm and inside work, when the time is right news will be released And they've made all 2p
They can soon pull the carpet